When clinicians at the Children’s Hospital of Philadelphia (CHOP) treated baby KJ – born with a rare, often-fatal urea-cycle disorder – with a CRISPR...
At the beginning of a genome editing revolution one of the great challenges is the need for a common language. For the last two years, The National...
Genome editing and its potential uses are highly complex and can be challenging to comprehend for laypeople. A global citizens’ assembly is proposed...
During clinical development, science is turned into medicine. Data from basic research, pre-clinical pharmacology and safety studies are put to the...
Samantha Maragh, US National Institute of Standards and Technology (NIST), discusses how the CRISPR genome editing revolution is both a big challenge...
